Sign in

CIK 0000875045 · Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330112644
Phone
6176792000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes Head of Corporate Development gave up 563 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 4 Shares withheld for taxes Chief Accounting Officer gave up 476 shares (to pay taxes)
  4. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 1,223 shares (to pay taxes)
  5. 4 Shares withheld for taxes Head of Development gave up 681 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, Human Resources gave up 1,040 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP Chief Legal Officer gave up 1,234 shares (to pay taxes)
  8. 4 Shares withheld for taxes Head of Development gave up 578 shares (to pay taxes)
  9. 8-K Event Executive or director change
  10. SCHEDULE 13D Stake Beneficial Ownership Report
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale Head of Development sold 110 shares at $157.21 ($17,293)
  13. 4 Shares withheld for taxes Chief Accounting Officer gave up 170 shares (to pay taxes)
  14. 144 Insider Sale of Securities
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 4 Gift EVP Chief Legal Officer gave 20,082 shares (gift)
  18. 4 Shares withheld for taxes Head of Research gave up 204 shares (to pay taxes)
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 8-K Event Executive or director change · Regulation FD disclosure

Page 8 of 137 · 2,721 filings